Standard Dosing of Paroxetine for Mixed Anxiety and Depressive Disorder
For adults with mixed anxiety and depressive disorder, start paroxetine at 10-20 mg once daily in the morning, with a standard therapeutic dose of 20-40 mg/day and a maximum of 50 mg/day. 1
Initial Dosing Strategy
- Start with 10-20 mg once daily, typically taken in the morning 1, 2
- The 20 mg starting dose represents both the minimal effective dose and the optimal dose for most patients 3
- For patients prone to anxiety or agitation as an initial side effect, consider starting with 10 mg/day as a "test dose" before increasing 1
Dose Titration
- If inadequate response after 1-3 weeks at 20 mg/day, increase in 10 mg increments 3
- Titrate no more frequently than weekly intervals 3
- For shorter half-life SSRIs like paroxetine, dose adjustments can occur at approximately 1-2 week intervals when titrating conservatively 1
- Maximum dose: 50 mg/day 1, 3
Standard Therapeutic Range
- 20-40 mg/day is the established therapeutic range for most patients 1
- The 20 mg dose is effective for both anxiety and depressive symptoms in the majority of patients 2, 4
- Doses of 40 mg/day have demonstrated efficacy in clinical trials for both generalized anxiety disorder and panic disorder 2
- Therapeutic plasma concentration range: 70-120 ng/mL 1
- Recent evidence suggests plasma concentrations of 65-120 ng/mL optimize efficacy while minimizing adverse effects 5
Important Clinical Considerations
Paroxetine is less activating but more anticholinergic than other SSRIs, making it particularly suitable for patients with prominent anxiety symptoms 1
Key Safety Points:
- Paroxetine has significant discontinuation syndrome risk due to its short half-life; taper slowly over 10-14 days when stopping 1
- Monitor for treatment-emergent suicidality, particularly in young adults 1
- Drug interactions via CYP2D6 inhibition require caution with co-administered medications 1
- Assess patient status and therapeutic response within 1-2 weeks of initiation 1
Duration of Treatment:
- Continue for 4-9 months after satisfactory response for first episode 1
- Longer duration (potentially indefinite) for patients with recurrent episodes 1
Efficacy Profile:
Paroxetine demonstrates effectiveness across the spectrum of mixed anxiety-depressive presentations, with FDA approval for major depressive disorder, generalized anxiety disorder, panic disorder, social anxiety disorder, OCD, and PTSD 2, 6, 4. This makes it particularly appropriate when anxiety and depression coexist, as the same medication addresses both symptom domains at standard doses 6, 4.